NCT05381831View on ClinicalTrials.gov

Natesto Spermatogenesis Reboot

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

April 21, 2025

Study Completion Date

April 21, 2025

Conditions

Hypogonadism, Male

Interventions

DRUG

NatestoTM

Administering daily intranasal testosterone, Natesto nasal gel is available as a metered-dose pump. One pump actuation delivers 5.5 mg of testosterone

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors

lead

University of Florida

OTHER